SEC Form 4 · accession 0001209191-19-002754
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V Cassella
Officer — Chief Development Officer
Period of report
Jan 4, 2019
Accepted (ET)
Jan 8, 2019 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $13.93 | Jan 4, 2019 | A | 75,000 | A | — | Jan 3, 2029 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1This option vests in sixteen equal quarterly installments beginning on April 4, 2019.